Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial

BACKGROUND: Blood pressure (BP) control and reduction of urinary protein excretion using agents that block the renin–angiotensin aldosterone system are the mainstay of therapy for chronic kidney disease (CKD). Research has confirmed the benefits in mild CKD, but data on angiotensin-converting enzyme...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Nephrol Dial Transplant
Huvudupphovsmän: Bhandari, Sunil, Ives, Natalie, Brettell, Elizabeth A., Valente, Marie, Cockwell, Paul, Topham, Peter S., Cleland, John G., Khwaja, Arif, El Nahas, Meguid
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2016
Ämnen:
CLINICAL SCIENCE
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4725389/
https://ncbi.nlm.nih.gov/pubmed/26429974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfv346
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk